AVA-016

N/A

Report date: 2023/01/08 11:27:03

Base Information

Drug NameAVA-016
Drug Alias NameAVA-016
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAlpha-2-antiplasmin inhibitors
TargetsAlpha-2-antiplasmin
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Group PLC
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Group PLC
Inactive CompaniesN/A
Active IndicationsBlood Coagulation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A